These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11043739)

  • 61. Increased skeletal uptake of Tc-99m methylene diphosphonate in milk-alkali syndrome.
    Campbell SB; Macfarlane DJ; Fleming SJ; Khafagi FA
    Clin Nucl Med; 1994 Mar; 19(3):207-11. PubMed ID: 8033469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 99m technetium diphosphonate bone imaging in Legg-Calvé-Perthes' disease.
    Tachdjian M
    Acta Orthop Belg; 1980; 46(4):366-70. PubMed ID: 7223384
    [No Abstract]   [Full Text] [Related]  

  • 63. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatic uptake of technetium-99m diphosphonate in thalassemia major.
    Levy HM; Smith R
    Clin Nucl Med; 1986 Feb; 11(2):110-2. PubMed ID: 3769335
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Altered biodistribution of Tc-99m MDP in a uremic and severely malnourished patient supported with enteral nutritional feeding.
    Arslan N; Ilgan S; Karaĉalioğlu AO; Oztürk E; Bayhan H
    Clin Nucl Med; 1999 Dec; 24(12):993-4. PubMed ID: 10595491
    [No Abstract]   [Full Text] [Related]  

  • 66. [Myocardial scintigraphy with technetium-99m diphosphonate following radiation therapy of the thoracic area (author's transl)].
    Neumann G; Standke E; Gottschild D
    Radiol Diagn (Berl); 1981; 22(5):690-6. PubMed ID: 7344002
    [No Abstract]   [Full Text] [Related]  

  • 67. Disappearance of soft tissue 99mTc diphosphonate activity following radiation therapy.
    Hill LT
    J Natl Med Assoc; 1981 Dec; 73(12):1119-21. PubMed ID: 7328686
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone scintigraphic demonstration of synovial chondromatosis.
    Smith R; Hulsey JM
    Clin Nucl Med; 1987 Feb; 12(2):120-2. PubMed ID: 3829535
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of technetium-99m diphosphonate and gallium-67 citrate bone scanning in the early diagnosis of infectious spondylodiscitis. A comparative study.
    Nolla-Solé JM; Mateo-Soria L; Rozadilla-Sacanell A; Mora-Salvador J; Valverde-García J; Roig-Escofet D
    Ann Rheum Dis; 1992 May; 51(5):665-7. PubMed ID: 1616335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Leakage assessment in adjustable laparoscopic gastric banding: radiography versus (99m)Tc-pertechnetate scintigraphy.
    Van Den Bossche B; Goethals I; Dierckx RA; Villeirs G; Pattyn P; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1128-31. PubMed ID: 12192556
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent.
    Qiu L; Lin J; Nan B; Lv G; Cheng W
    Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extensive soft tissue uptake of 99Tcm methylene diphosphonate in a patient with multiple myeloma.
    Evans JC; Murphy M; Eyes B
    Br J Radiol; 2000 Sep; 73(873):1018-20. PubMed ID: 11064661
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Preparation and preclinical pharmacological study on a novel bone imaging agent (99m)Tc-EMIDP.
    Lin J; Luo S; Chen C; Qiu L; Wang Y; Cheng W; Ye W; Xia Y
    Appl Radiat Isot; 2010 Sep; 68(9):1616-22. PubMed ID: 20363146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bone turnover in postmenopausal osteoporosis. Determined by whole body retention and urinary excretion of 99m-technetium diphosphonate.
    Thomsen K
    Dan Med Bull; 1988 Oct; 35(5):468-79. PubMed ID: 3066591
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
    Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
    J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
    [TBL] [Abstract][Full Text] [Related]  

  • 77. I-123 uptake by intrathoracic stomach.
    Sathekge MM; Mokgoro NP; Mpikashe P; Ramafi OE
    Clin Nucl Med; 2005 Jan; 30(1):42. PubMed ID: 15604972
    [No Abstract]   [Full Text] [Related]  

  • 78. [Negative bone scintigraphy in osteomyelitis in children. Difficulties in interpretation].
    Berard J; Michel CR; Chauvot P
    Rev Chir Orthop Reparatrice Appar Mot; 1982; 68(7):475-9. PubMed ID: 6220442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extensive extraosseous localization of bone imaging agent in a patient with renal failure and rhabdomyolysis accompanied by combined hypercalcemia and hyperphosphatemia.
    Shih WJ; Flueck J; O'Connor W; Domstad PA
    Clin Nucl Med; 1989 Mar; 14(3):163-7. PubMed ID: 2544339
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diffuse pulmonary uptake of Tc-99m sestamibi due to chemical pneumonitis.
    Pham R; Bellezuoli E
    J Nucl Cardiol; 2006; 13(1):127-9. PubMed ID: 16464728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.